ReviewFrontiers in immunology2026

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis.

Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.